CytoSorb, a novel therapeutic approach for patients with septic shock: A case report

International Journal of Artificial Organs

Volumn 38, Issue 8, 2015, Pages 461-464

  Hinz, Burkhard ^a   Jauch, Oliver ^a   Noky, Toralf ^a   Friesecke, Sigrun ^b   Abel, Peter ^b   Kaiser, Rolf ^a  

^a KMG Clinic Güstrow   (Germany)

^b UNIVERSITY MEDICINE GREIFSWALD   (Germany)

Author keywords

Cytokine adsorption; CytoSorb; Hemoadsorption; Sepsis; Septic shock

Indexed keywords

PATIENT TREATMENT;

% REDUCTIONS; CASE REPORTS; CYTOKINE ADSORPTION; CYTOKINES; CYTOSORB; HAEMODYNAMICS; HEMOADSORPTION; SEPSIS; SEPTIC SHOCKS; SYSTEMIC INFLAMMATION;

HEMODYNAMICS;

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; C REACTIVE PROTEIN; CEFTAZIDIME; CLARITHROMYCIN; CREATININE; DAPTOMYCIN; FUROSEMIDE; HYDROCORTISONE; NORADRENALIN; PROCALCITONIN; CYTOKINE;

AGED; ARTICLE; BLOOD GAS ANALYSIS; BODY TEMPERATURE; CASE REPORT; CONTINUOUS RENAL REPLACEMENT THERAPY; GLOMERULUS FILTRATION RATE; HEMODYNAMICS; HUMAN; INTERVERTEBRAL DISK DEGENERATION; LEUKOCYTE COUNT; LIVER DYSFUNCTION; LUNG EXTRAVASCULAR FLUID; MALE; METABOLIC ACIDOSIS; NEUTROPHILIA; PARTIAL THROMBOPLASTIN TIME; SEPTIC SHOCK; THROMBOCYTE COUNT; URINALYSIS; URINE VOLUME; BLOOD; DEVICES; HEMOFILTRATION; SHOCK, SEPTIC;

AGED; CYTOKINES; HEMOFILTRATION; HUMANS; MALE; SHOCK, SEPTIC;

EID: 84942324670     PISSN: 03913988     EISSN: 17246040     Source Type: Journal    
DOI: 10.5301/ijao.5000429     Document Type: Article

References (9)

1. Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med. 2013;369(9):840-851.
2. Rimmelé T, Kellum JA. Clinical review: blood purification for sepsis. Crit Care. 2011;15(1):205.
3. Kellum JA, Song M, Venkataraman R. Hemoadsorption removes tumor necrosis factor, interleukin-6, and interleukin-10, reduces nuclear factor-kappaB DNA binding, and improves short-term survival in lethal endotoxemia. Crit Care Med. 2004;32(3):801-805.
4. Peng ZY, Carter MJ, Kellum JA. Effects of hemoadsorption on cytokine removal and short-term survival in septic rats. Crit Care Med. 2008;36(5):1573-1577.
5. Sathe P, Sakhavalkar P, Kumar S, Choudhary S. Clinical experience of using a novel extracorporeal cytokine adsorption column for treatment of septic shock with multiorgan failure. Crit Care. 2015;19(Suppl 1):P130.
6. Basu R, Pathak S, Goyal J, Chaudhry R, Goel RB, Barwal A. Use of a novel hemoadsorption device for cytokine removal as adjuvant therapy in a patient with septic shock with multiorgan dysfunction: A case study. Indian J Crit Care Med. 2014; 18(12):822-824.
7. Tomescu D, Dima SO, Tănăsescu S, Tănase CP, Năstase A, Popescu M. Effects of a novel cytokine haemoadsorbtion system on inflammatory response in septic shock after cephalic pancreatectomy - a case report. Romanian Journal of Anaesthesia and Intensive Care. 2014;21(2):134-138.
8. Hetz H, Berger R, Recknagel P, Steltzer H. Septic shock secondary to β-hemolytic streptococcus-induced necrotizing fasciitis treated with a novel cytokine adsorption therapy. Int J Artif Organs. 2014;37(5):422-426.
9. Mitzner SR, Gloger M, Henschel J, Koball S. Improvement of hemodynamic and inflammatory parameters by combined hemoadsorption and hemodiafiltration in septic shock: a case report. Blood Purif. 2013;35(4):314-315.